Home/Pipeline/EndoShunt Device

EndoShunt Device

Traumatic Abdominal Hemorrhage Control

Pre-clinicalActive

Key Facts

Indication
Traumatic Abdominal Hemorrhage Control
Phase
Pre-clinical
Status
Active
Company

About EndoShunt

EndoShunt is a pre-revenue medical device startup targeting the critical unmet need for rapid hemorrhage control in trauma surgery. Its core technology is a guidewire-free, length-adjustable, temporary shunt designed to be deployed in under 30 seconds to stop bleeding from major abdominal vascular injuries. The company has developed functional prototypes validated in benchtop and in vivo studies, has a defined regulatory pathway for FDA 510(k) clearance as a Class II device, and is seeking $2M in funding to achieve clearance and initiate a targeted pilot launch.

View full company profile

Therapeutic Areas